Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Sastre-Garriga

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2018
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - NOJaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 24, 2018
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - CommentaryJaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Leptomeningeal enhancement in Susac's syndrome and multiple sclerosis: Time to expect the unexpected?Jaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2015
Highlights from the 31st ECTRIMS congress - Barcelona 2015Jaume Sastre-Garriga, Heinz Wiendl
The Lancet. Neurology|September 7, 2014
Diagnosis and trials of clinically isolated syndromeXavier Montalban, Jaume Sastre-Garriga
Nature Reviews. Neurology|December 7, 2010
Multiple sclerosis: Lesion location may predict disability in multiple sclerosisJaume Sastre-Garriga, Mar Tintoré
Nature Reviews. Neurology|July 23, 2016
Multiple sclerosis: Dimethyl fumarate is coming of ageMar Tintoré, Jaume Sastre-Garriga
Journal of the Neurological Sciences|June 3, 2014
Predictive markers of disease evolution after a CIS in everyday practiceGeorgina Arrambide, Jaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 31, 2019
EditorialPeter Feys, Jaume Sastre-Garriga
Journal of the Neurological Sciences|September 30, 2008
New treatment measurements for treatment effects on relapses and progressionMar Tintoré, Jaume Sastre-Garriga
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2018
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - NOJaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 24, 2018
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - CommentaryJaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Leptomeningeal enhancement in Susac's syndrome and multiple sclerosis: Time to expect the unexpected?Jaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2015
Highlights from the 31st ECTRIMS congress - Barcelona 2015Jaume Sastre-Garriga, Heinz Wiendl
The Lancet. Neurology|September 7, 2014
Diagnosis and trials of clinically isolated syndromeXavier Montalban, Jaume Sastre-Garriga
Nature Reviews. Neurology|December 7, 2010
Multiple sclerosis: Lesion location may predict disability in multiple sclerosisJaume Sastre-Garriga, Mar Tintoré
Nature Reviews. Neurology|July 23, 2016
Multiple sclerosis: Dimethyl fumarate is coming of ageMar Tintoré, Jaume Sastre-Garriga
Journal of the Neurological Sciences|June 3, 2014
Predictive markers of disease evolution after a CIS in everyday practiceGeorgina Arrambide, Jaume Sastre-Garriga
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 31, 2019
EditorialPeter Feys, Jaume Sastre-Garriga
Journal of the Neurological Sciences|September 30, 2008
New treatment measurements for treatment effects on relapses and progressionMar Tintoré, Jaume Sastre-Garriga
Pageof 21